Boparan - comment

The CMA decision to instigate an in-depth probe into the 2 Sisters/ForFarmers merger doesn’t move the needle for Boparan. Benefits from the merged business would flow to the Boparan family office. If anything, a failure to complete the merger would leave open a cross-subsidy opportunity if the feed price ratchet agreements with the supermarkets broke down in the future.

https://www.reuters.com/markets/deals/uk-competition-watchdog-directs-in-depth-probe-into-forfarmer-boparan-deal-2023-01-09/